CAS: 1441000-45-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide REF: 3D-RHC00045CAS: 1441000-45-8 | Min. 95% | To inquire | Tue 18 Feb 25 |
 | Opiranserin REF: TM-T16399CAS: 1441000-45-8 | 98% | 907.00 €~2,337.00 € | Mon 24 Feb 25 |
![4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide](https://static.cymitquimica.com/products/3D/thumb/RHC00045.jpg)
4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide
CAS:1441000-45-8
4-Butoxy-N-[4-(dimethylamino)oxan-4-yl]methyl]-3,5-dimethoxybenzamide (BDMOB) is a molecule that has been shown to act as a serotonin receptor …
Formula:
C21H34N2O5
Purity:
Min. 95%
Molecular weight:
394.5 g/mol
Ref: 3D-RHC00045
| 25mg | 229.00 € | ||
| 250mg | 912.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Opiranserin
CAS:1441000-45-8
Opiranserin is a development as an injectable agent for the treatment of postoperative pain.
Formula:
C21H34N2O5
Purity:
98%
Color and Shape:
Solid
Molecular weight:
394.51
- Inhibitors
- Neuroscience
- 5-HT Receptor
- GlyT
- See more categories
- GPCR/G-Protein
Ref: TM-T16399
| 25mg | 1,410.00 € | ||
| 50mg | 1,851.00 € | ||
| 100mg | 2,337.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
